Read + Share
Amedeo Smart
Independent Medical Education
Dyer O. FDA calls for investigation into industry influence during Alzheimer's drug approval. BMJ 2021;374:n1778.PMID: 34253567
Email
LinkedIn
Facebook
Twitter
Free Medical Abstracts Privacy Policy